These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23124658)
21. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Hwang JT; Lee MS; Kim HJ; Sung MJ; Kim HY; Kim MS; Kwon DY Phytother Res; 2009 Feb; 23(2):262-6. PubMed ID: 18844326 [TBL] [Abstract][Full Text] [Related]
22. Mass production of the ginsenoside Rg3(S) through the combinative use of two glycoside hydrolases. Kim JK; Cui CH; Liu Q; Yoon MH; Kim SC; Im WT Food Chem; 2013 Nov; 141(2):1369-77. PubMed ID: 23790926 [TBL] [Abstract][Full Text] [Related]
23. A ginsenoside G-Rg3 PEGylated long-circulating liposome for hyperglycemia and insulin resistance therapy in streptozotocin-induced type 2 diabetes mice. Han S; Zhang X; Li Z; Cui G; Xue B; Yu Y; Guo J; Zhang H; Yang J; Teng L Eur J Pharm Biopharm; 2024 Aug; 201():114350. PubMed ID: 38848783 [TBL] [Abstract][Full Text] [Related]
24. Antidiabetic effects of malonyl ginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin. Liu Z; Li W; Li X; Zhang M; Chen L; Zheng YN; Sun GZ; Ruan CC J Ethnopharmacol; 2013 Jan; 145(1):233-40. PubMed ID: 23147499 [TBL] [Abstract][Full Text] [Related]
25. Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats. Lai DM; Tu YK; Liu IM; Chen PF; Cheng JT Planta Med; 2006 Jan; 72(1):9-13. PubMed ID: 16450289 [TBL] [Abstract][Full Text] [Related]
26. Liquid chromatography/tandem mass spectrometry for pharmacokinetic studies of 20(R)-ginsenoside Rg3 in dog. Li K; Chen X; Xu J; Li X; Zhong D Rapid Commun Mass Spectrom; 2005; 19(6):813-7. PubMed ID: 15714599 [TBL] [Abstract][Full Text] [Related]
27. Effects of R type and S type ginsenoside Rg3 on DNA methylation in human hepatocarcinoma cells. Teng S; Wang Y; Li P; Liu J; Wei A; Wang H; Meng X; Pan D; Zhang X Mol Med Rep; 2017 Apr; 15(4):2029-2038. PubMed ID: 28260016 [TBL] [Abstract][Full Text] [Related]
28. Arabinoxylan Attenuates Type 2 Diabetes by Improvement of Carbohydrate, Lipid, and Amino Acid Metabolism. Nie Q; Chen H; Hu J; Gao H; Fan L; Long Z; Nie S Mol Nutr Food Res; 2018 Oct; 62(20):e1800222. PubMed ID: 30211972 [TBL] [Abstract][Full Text] [Related]
29. High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies. Xie HT; Wang GJ; Sun JG; Tucker I; Zhao XC; Xie YY; Li H; Jiang XL; Wang R; Xu MJ; Wang W J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):167-73. PubMed ID: 15734156 [TBL] [Abstract][Full Text] [Related]
30. Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration. Liu C; Hu M; Guo H; Zhang M; Zhang J; Li F; Zhong Z; Chen Y; Li Y; Xu P; Li J; Liu L; Liu X Drug Metab Dispos; 2015 Nov; 43(11):1702-10. PubMed ID: 26265741 [TBL] [Abstract][Full Text] [Related]
31. Ginsenoside Rg3 Protects against Diabetic Cardiomyopathy and Promotes Adiponectin Signaling via Activation of PPAR-γ. Zhang C; Yu H; Ye J; Tong H; Wang M; Sun G Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069059 [TBL] [Abstract][Full Text] [Related]
32. Stereoselective determination of ginsenosides Rg3 and Rh2 epimers in rat plasma by LC-MS/MS: application to a pharmacokinetic study. Bae SH; Zheng YF; Yoo YH; Kim JY; Kim SO; Jang MJ; Seo JH; Bae SK J Sep Sci; 2013 Jun; 36(12):1904-12. PubMed ID: 23559579 [TBL] [Abstract][Full Text] [Related]
33. Chemical differentiation and quality evaluation of commercial Asian and American ginsengs based on a UHPLC-QTOF/MS/MS metabolomics approach. Chen Y; Zhao Z; Chen H; Yi T; Qin M; Liang Z Phytochem Anal; 2015; 26(2):145-60. PubMed ID: 25448530 [TBL] [Abstract][Full Text] [Related]
34. Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry. Wan JY; Liu P; Wang HY; Qi LW; Wang CZ; Li P; Yuan CS J Chromatogr A; 2013 Apr; 1286():83-92. PubMed ID: 23499252 [TBL] [Abstract][Full Text] [Related]
35. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin. Xu R; Peng Y; Wang M; Fan L; Li X J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586 [TBL] [Abstract][Full Text] [Related]
36. Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514. Cheng LQ; Na JR; Bang MH; Kim MK; Yang DC Phytochemistry; 2008 Jan; 69(1):218-24. PubMed ID: 17764709 [TBL] [Abstract][Full Text] [Related]
37. Metabolomics analysis reveals the renal protective effect of Panax ginseng C. A. Mey in type 1 diabetic rats. Wang XS; Hu MX; Guan QX; Men LH; Liu ZY Chin J Nat Med; 2022 May; 20(5):378-386. PubMed ID: 35551772 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic and metabolic studies of ginsenoside Rb3 in rats using RRLC-Q-TOF-MS. Zhao L; Ma Y; Chen C; Liu S; Wu W J Chromatogr Sci; 2018 Jul; 56(6):480-487. PubMed ID: 29897460 [TBL] [Abstract][Full Text] [Related]
39. LC-MS based metabolic and metabonomic studies of Panax ginseng. Wu W; Jiao C; Li H; Ma Y; Jiao L; Liu S Phytochem Anal; 2018 Jul; 29(4):331-340. PubMed ID: 29460310 [TBL] [Abstract][Full Text] [Related]
40. Linking biological activity with herbal constituents by systems biology-based approaches: effects of Panax ginseng in type 2 diabetic Goto-Kakizaki rats. Hu C; Wei H; Kong H; Bouwman J; Gonzalez-Covarrubias V; van der Heijden R; Reijmers TH; Bao X; Verheij ER; Hankemeier T; Xu G; van der Greef J; Wang M Mol Biosyst; 2011 Nov; 7(11):3094-103. PubMed ID: 21901208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]